The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for chronic lung disease bronchiectasis in the US. The regulator has set a ...

Portfolio management, financial planning, trustee, responsible entity and compliance services, executor services, investment administration and custody services.

Here's a pretty strange Roblox game, where you play as a student in a classroom. Unlike in a real school, you can pay points to do absurd things like throw a toilet, scream at your teacher, break your ...

The hallmark of CF is progressive, obstructive lung disease due to abnormal airway secretions, leading to chronic airway infection, excessive inflammation, bronchiectasis and parenchymal damage.2 Over ...